Beyond Efficacy and Safety: Where We Go From Here in the Management of Multiple SclerosisByApril 5th 2018
Expert Perspective on Evolving Diagnostic and Therapeutic Strategies in Multiple Sclerosis With Ben Thrower, MDByApril 5th 2018
A Payer Point of View on the Changing Multiple Sclerosis Treatment Spectrum, With Kenneth Snow, MDByApril 5th 2018
